These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18614932)

  • 1. Interaction of hepatitis B and C viruses in patients infected with HIV.
    Rong-Rong Y; Xi-En G; Shi-Cheng G; Yong-Xi Z
    J Acquir Immune Defic Syndr; 2008 Aug; 48(4):505-6. PubMed ID: 18614932
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
    Morsica G; Bagaglio S; Cicconi P; Capobianchi MR; Pellizzer G; Caramello P; Orani A; Moioli C; Rizzardini G; Uberti-Foppa C; Puoti M; Monforte AD;
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):574-81. PubMed ID: 19590432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
    De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
    Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR; Gui X; Chen XY; Zhu Y
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa.
    Vermeulen M; Swanevelder R; Chowdhury D; Ingram C; Reddy R; Bloch EM; Custer BS; Murphy EL;
    Emerg Infect Dis; 2017 Sep; 23(9):1560-1563. PubMed ID: 28820374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
    Wongprasit P; Manosuthi W; Kiertiburanakul S; Sungkanuparph S
    AIDS Patient Care STDS; 2010 Apr; 24(4):205-9. PubMed ID: 20377434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients.
    Filippini P; Coppola N; Pisapia R; Martini S; Marrocco C; Di Martino F; Sagnelli C; Filippini A; Sagnelli E
    J Med Virol; 2007 Nov; 79(11):1679-85. PubMed ID: 17854026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
    Galluzzo C; Liotta G; Andreotti M; Luhanga R; Jere H; Mancinelli S; Maulidi M; Sagno JB; Pirillo M; Erba F; Amici R; Ceffa S; Marazzi MC; Vella S; Palombi L; Giuliano M
    J Med Virol; 2012 Oct; 84(10):1553-7. PubMed ID: 22930502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
    de Vries-Sluijs TE; van der Eijk AA; Hansen BE; Osterhaus AD; de Man RA; van der Ende ME
    J Clin Virol; 2006 May; 36(1):60-3. PubMed ID: 16418013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B immune reconstitution syndrome in a patient with HIV infection.
    John MA; Gosnell BI; Manzini TC; Ramdial P; Moosa MS
    Int J STD AIDS; 2016 Oct; 27(12):1126-1129. PubMed ID: 26769756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of hepatocellular carcinoma type C and B by quantitation of serum HCV-RNA and HBV-DNA using branched DNA probe assay].
    Teramoto T; Iwabuchi S; Takatori M; Iino S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):787-95. PubMed ID: 7563876
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio CL
    AIDS; 2006 Apr; 20(6):863-70. PubMed ID: 16549970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
    Benhamou Y; Bochet M; Thibault V; Di Martino V; Caumes E; Bricaire F; Opolon P; Katlama C; Poynard T
    Hepatology; 1999 Nov; 30(5):1302-6. PubMed ID: 10534354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of serum NV-F virus DNA concentrations in samples from patients coinfected with hepatitis B or C virus.
    Hsu CW; Cheng JC; Yeh CT
    J Clin Microbiol; 2006 Sep; 44(9):3130-3. PubMed ID: 16954237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
    Meng Q; Wong C; Rangachari A; Tamatsukuri S; Sasaki M; Fiss E; Cheng L; Ramankutty T; Clarke D; Yawata H; Sakakura Y; Hirose T; Impraim C
    J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
    Matthews GV; Avihingsanon A; Lewin SR; Amin J; Rerknimitr R; Petcharapirat P; Marks P; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ
    Hepatology; 2008 Oct; 48(4):1062-9. PubMed ID: 18697216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statements from the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), Toulon, France, May 28-30, 2008.
    Haubrich R; Soriano V; Lafeuillade A
    HIV Clin Trials; 2008; 9(5):348-65. PubMed ID: 18977724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients].
    Rey D; Fritsch S; Schmitt C; Partisani M; Kempf-Durepaire G; Nicolle M; Krantz V; De Mautort E; Stoll-Keller F; Lang JM
    Gastroenterol Clin Biol; 2000 Jan; 24(1):125-7. PubMed ID: 10679599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.